These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16938650)

  • 1. Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C.
    Dai CY; Chuang WL; Hsieh MY; Lee LP; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
    Transl Res; 2006 Sep; 148(3):128-33. PubMed ID: 16938650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin.
    Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Hsieh MY; Hou NJ; Lin ZY; Hsieh MY; Wang LY; Yu ML
    Antiviral Res; 2005 Aug; 67(2):93-7. PubMed ID: 16051377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C.
    Dai CY; Chuang WL; Lee LP; Pan WC; Huang JF; Hsieh MY; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Yu ML
    Transl Res; 2008 Oct; 152(4):151-6. PubMed ID: 18940717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity.
    Bouzgarrou N; Hassen E; Farhat K; Bahri O; Gabbouj S; Maamouri N; Ben Mami N; Saffar H; Trabelsi A; Triki H; Chouchane L
    Hum Immunol; 2009 Apr; 70(4):230-6. PubMed ID: 19480854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.
    Schirren CA; Jung MC; Gerlach JT; Worzfeld T; Baretton G; Mamin M; Hubert Gruener N; Houghton M; Pape GR
    Hepatology; 2000 Sep; 32(3):597-603. PubMed ID: 10960455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.
    Suzuki F; Arase Y; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Satoh J; Kumada H
    J Viral Hepat; 2004 May; 11(3):271-6. PubMed ID: 15117331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.
    Tsukada H; Ochi H; Maekawa T; Abe H; Fujimoto Y; Tsuge M; Takahashi H; Kumada H; Kamatani N; Nakamura Y; Chayama K
    Gastroenterology; 2009 May; 136(5):1796-805.e6. PubMed ID: 19208361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patients.
    Sermasathanasawadi R; Kato N; Muroyama R; Dharel N; Shao RX; Chang JH; Li CZ; Kawabe T; Omata M
    Liver Int; 2008 Jul; 28(6):798-806. PubMed ID: 18397234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of tumour necrosis factor alpha promoter polymorphisms at position -308 and -238 with clinical characteristics of chronic hepatitis C.
    Dai CY; Chuang WL; Lee LP; Chen SC; Hou NJ; Lin ZY; Hsieh MY; Hsieh MY; Wang LY; Chang WY; Yu ML
    J Viral Hepat; 2006 Nov; 13(11):770-4. PubMed ID: 17052277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C.
    Mirandola S; Osterreicher CH; Marcolongo M; Datz C; Aigner E; Schlabrakowski A; Realdon S; Gerotto M; Alberti A; Stickel F
    Liver Int; 2009 Apr; 29(4):557-65. PubMed ID: 19018985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.
    Schott E; Witt H; Pascu M; van Boemmel F; Weich V; Bergk A; Halangk J; Müller T; Puhl G; Wiedenmann B; Berg T
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):947-51. PubMed ID: 18049163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 study.
    Bonilla N; Barget N; Andrieu M; Roulot D; Letoumelin P; Grando V; Trinchet JC; Ganne-Carrié N; Beaugrand M; Deny P; Choppin J; Guillet J; Ziol M
    J Viral Hepat; 2006 Jul; 13(7):474-81. PubMed ID: 16792541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
    Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on TAQ1 polymorphism in the 3'untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3.
    Suneetha PV; Goyal A; Hissar SS; Sarin SK
    J Med Virol; 2006 Aug; 78(8):1055-60. PubMed ID: 16789008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between IFN-gamma+874 polymorphisms and the clinical outcomes of hepatitis B and/or hepatitis C virus infection.].
    Gao QJ; Liu DW; Zhang SY; Jia M; Wu LH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Mar; 31(3):324-8. PubMed ID: 20510064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus.
    Wozniak MA; Itzhaki RF; Faragher EB; James MW; Ryder SD; Irving WL;
    Hepatology; 2002 Aug; 36(2):456-63. PubMed ID: 12143056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.